Two healthy growth engines are now driving AMETEK
- Q1 2026 sales rose 11.3% to $1.93 billion, helped by 5% organic growth and recent acquisitions.
- EIG turned positive again with 2% organic growth and an impressive 25% surge in organic orders.
- EMG stayed very strong with record Q1 sales of $664 million and 11% organic growth.
- The company ended Q1 with a record $3.87 billion backlog, giving excellent sales visibility for 2026.
- The main worry is whether newly acquired businesses like First Aviation Services can quickly match historical margin levels.
A cleaner two-part recovery
AMETEK is currently operating from a position of broad strength. In Q1 2026, total sales grew 11.3% to $1.93 billion. Organic growth, which strips out acquisitions and currency impacts, was a solid 5%. This matters because it proves customers are buying more products naturally, rather than the company simply buying growth through deals.
The most critical shift is in the Electronic Instruments Group, or EIG. This larger segment had been a weak spot in 2025. In Q1 2026, EIG not only returned to 2% organic sales growth, but organic orders jumped 25%. This surge in forward demand definitively answers prior concerns about the segment's recovery.
Meanwhile, the Electromechanical Group, or EMG, continues to act as a powerful secondary engine. Its Q1 sales reached $664 million, up 12.9%, fueled by 11% organic growth. The combination of EIG's order inflection and EMG's steady double-digit growth gives AMETEK excellent momentum and a record $3.87 billion backlog.
The focus now shifts to margin execution. AMETEK recently acquired First Aviation Services for defense exposure and previously bought FARO and LKC Technologies. While the company is famous for its operational discipline, integrating these businesses without persistently diluting overall operating margins remains the primary test for management in late 2026.
Buy niche leaders, improve them
AMETEK makes high-value parts and instruments that customers use in critical jobs. Many of its products measure, test, control, connect, or move something important. If an industrial plant, aircraft, power system, or medical device depends on precision, AMETEK wants to supply the tool behind it.
The company runs a decentralized model. Many smaller business units operate close to their customers, while the corporate parent dictates cost control, pricing strategy, and capital discipline. AMETEK consistently buys niche technology companies and then applies this playbook to raise their margins over time.
This strategy works beautifully because industrial and medical customers often care more about reliability than finding the absolute lowest price. However, the model has an obvious weakness. If AMETEK overpays for acquisitions, struggles to integrate them, or buys lower-margin businesses for too long, the compounding growth story can stall.
Precise tools for hard jobs
Process and analytical instruments
These EIG products monitor, test, calibrate, and analyze industrial processes. They are essential where accuracy, uptime, and safety are non-negotiable.
Aerospace and power products
AMETEK sells instruments and engineered components into aerospace and power markets. Customer requirements are strict and highly regulated.
Automation and engineered solutions
EMG includes motors, motion control systems, and specialty metals. This group delivered 11% organic growth in Q1 2026.
First Aviation Services
Acquired in Q1 2026, this business provides defense and aviation maintenance, repair, and overhaul services.
FARO 3D measurement
FARO joined EIG in 2025. Its portable measurement arms and laser scanners add modern 3D measurement capabilities.
EIG is larger, EMG is faster
Segment mix is based on Q1 2026 sales: EIG at $1.26 billion and EMG at $664 million. EIG is the larger business, while EMG has recently grown faster organically.
What could break the story
Acquisition margins stay diluted
High impact · Medium oddsAMETEK's model depends on buying smaller technology businesses and improving them. Recent deals have slightly diluted EIG operating margins. If that drag persists, earnings growth may lag sales growth.
Industrial slowdown hits both engines
Medium impact · Medium oddsAMETEK sells into many industrial, aerospace, power, and medical markets. That spread helps, but weaker customer budgets during a global economic stall could hurt new orders.
EIG order momentum fades
High impact · Low oddsEIG saw a massive 25% organic order jump in Q1 2026. If this proves to be a temporary spike rather than a sustained recovery trend, the segment could struggle against tougher growth comparisons later in the year.
Valuation leaves less room for mistakes
Medium impact · Medium oddsAMETEK is a high-quality industrial compounder, and investors price it that way. If organic growth slows or acquisition returns disappoint, the stock may face pressure.
In one breath
What does AMETEK actually make?
AMETEK makes electronic instruments and electromechanical devices. In plain English, it sells tools that measure, test, monitor, connect, control, or move things in industrial, aerospace, power, and medical settings.
Why does AMETEK buy so many companies?
Acquisitions are central to its model. AMETEK buys niche technology businesses, adds them to its decentralized structure, and tries to improve sales, costs, and margins over time.
What changed most in 2026?
The larger segment, EIG, returned to positive organic growth in Q1 2026 and posted a 25 percent jump in organic orders. That joined the strong growth already happening in EMG, proving the company has two healthy growth engines.
What is the biggest thing to watch next?
Watch EIG margin recovery. Recent deals helped sales, but they also diluted EIG operating margins slightly, so the key question is whether AMETEK can raise the margins of its acquired businesses.
